bromodeoxyuridine has been researched along with catechol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Hasegawa, R; Hirose, M; Hoshiya, T; Ito, N; Shirai, T; Takaba, K; Tiwawech, D | 1 |
2 other study(ies) available for bromodeoxyuridine and catechol
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Suppression of diethylnitrosamine-initiated preneoplastic foci development in the rat liver by combined administration of four antioxidants at low doses.
Topics: Animals; Antioxidants; Benzodioxoles; Body Weight; Bromodeoxyuridine; Butylated Hydroxyanisole; Catechols; Diethylnitrosamine; Dose-Response Relationship, Drug; Drug Synergism; Glutathione Transferase; Hydroquinones; Liver; Liver Neoplasms, Experimental; Male; Organ Size; Phenols; Precancerous Conditions; Rats; Rats, Inbred F344 | 1992 |